Cargando…
Innate Immune Regulation and Cancer Immunotherapy
There has been major growth in understanding innate immune signaling, inflammation, immune suppression and cancer immunotherapy. Innate immune regulation and cancer immunotherapy highlights emerging research about the underlying mechanisms of innate immunity and signaling regulation, inflammation an...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2012.
|
| Edición: | 1st ed. 2012. |
| Temas: | |
| Acceso en línea: | Texto Completo |
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-1-4419-9914-6 | ||
| 003 | DE-He213 | ||
| 005 | 20220114223833.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 111129s2012 xxu| s |||| 0|eng d | ||
| 020 | |a 9781441999146 |9 978-1-4419-9914-6 | ||
| 024 | 7 | |a 10.1007/978-1-4419-9914-6 |2 doi | |
| 050 | 4 | |a RC261-271 | |
| 072 | 7 | |a MJCL |2 bicssc | |
| 072 | 7 | |a MED062000 |2 bisacsh | |
| 072 | 7 | |a MJCL |2 thema | |
| 082 | 0 | 4 | |a 571.978 |2 23 |
| 082 | 0 | 4 | |a 616.994 |2 23 |
| 245 | 1 | 0 | |a Innate Immune Regulation and Cancer Immunotherapy |h [electronic resource] / |c edited by Rong-Fu Wang. |
| 250 | |a 1st ed. 2012. | ||
| 264 | 1 | |a New York, NY : |b Springer New York : |b Imprint: Springer, |c 2012. | |
| 300 | |a X, 478 p. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 505 | 0 | |a Introduction -- The role of NKT cells in the immune regulation of neoplastic disease.- γδ T Cells in Cancer -- Toll-like receptors and their regulatory mechanisms -- Cytoplasmic sensing of viral double-stranded RNA and activation of innate immunity by RIG-I-Like Receptors -- Innate immune signaling and negative regulators in cancer -- Dendritic Cell Subsets and Immune Regulation -- Human Dendritic Cells in Cancer -- Regulatory T cells in cancer -- Relationship between Th17 and regulatory T cells in the tumor environment -- Mechanisms and control of regulatory T cells in cancer -- Myeloid Derived Suppressor Cells in Cancer -- Myeloid Derived Suppressor Cells and Treg cells in Tumor Microenvironment -- Cell Surface Co-Signaling Molecules in the Control of Innate and Adaptive Cancer Immunity -- Negative regulators of NF-κB activation and type I interferon pathways -- Role of TGF-β in immune suppression and inflammation -- Indoleamine 2,3-dioxygenase and tumor-induced immune suppression -- Myeloid-Derived Suppressor Cells in Cancer: Mechanisms and Therapeutic Perspectives -- Human tumor antigens recognized by T cells and their implications for cancer immunotherapy -- Cancer/testis (CT) Antigens: Potential Targets for Immunotherapy -- Tumor antigens and Immune Regulation in Cancer Immunotherapy -- Immunotherapy of Cancer -- Current Progress in Adoptive T-Cell Therapy of Lymphoma -- Adoptive Immunotherapy of Melanoma -- Index. | |
| 520 | |a There has been major growth in understanding innate immune signaling, inflammation, immune suppression and cancer immunotherapy. Innate immune regulation and cancer immunotherapy highlights emerging research about the underlying mechanisms of innate immunity and signaling regulation, inflammation and immune suppression that promote or inhibit cancer development and progression, and offers novel ideas and strategies to develop therapeutic cancer drugs or cell therapy by manipulating or blocking these negative signaling pathways and generating potent antitumor immunity. Recent studies have identified key innate immune receptors or sensors, novel signaling molecules and immune regulatory molecules that control immune responses, inflammation and immune suppression in cancer and other diseases. Major progresses in understanding of tumor antigens, immune suppressive molecules and cell population and novel vaccine strategies bring therapeutic cancer vaccines and drugs in realty. With chapters written by internationally recognized contributors, this book provides essential introduction and guide for immunologists, basic, translational and clinical cancer researchers. Features of this book: Offers the most recent development from basic science to clinical application of cancer immunotherapy, thus serving useful guide for immunologists, and cancer researcher and oncologists. Identify key immune signaling molecules and cell populations that dampen immune responses against cancer, thus providing novel strategies to develop therapeutic cancer vaccines and drugs. | ||
| 650 | 0 | |a Cancer. | |
| 650 | 0 | |a Immunology. | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 1 | 4 | |a Cancer Biology. |
| 650 | 2 | 4 | |a Immunology. |
| 650 | 2 | 4 | |a Pharmacology. |
| 700 | 1 | |a Wang, Rong-Fu. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9781441999139 |
| 776 | 0 | 8 | |i Printed edition: |z 9781489985903 |
| 776 | 0 | 8 | |i Printed edition: |z 9781441999153 |
| 856 | 4 | 0 | |u https://doi.uam.elogim.com/10.1007/978-1-4419-9914-6 |z Texto Completo |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||